Latest news

December 2019

  • NEAD group Christmas symposium about risk in psychiatry and clinical trials, December 2019

May 2019
  • Click here to read the Lundbeckfonden News article, "Topforsker - med baby på armen", which includes an interview with Professor Kamilla Miskowiak.

November 2018
October 2018
  • The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force chaired by Professor Miskowiak has developed a patient booklet with information about the nature of cognitive dysfunction in patients with bipolar disorder and a practical guide on how to facilitate cognitive capacity and compensate for cognitive problems in daily life (

    Click below to access the booklet and read more about why, when, and how to assess and address cognition in these patients.

    English version:

    Danish version:

June 2018
  • NEAD Group was well represented among poster presenters at the annual Psychiatric Research Day ("Region Hovedstadens Psykiatris Forskningsdag"), which took place at Rigshospitalet, Copenhagen,
    Denmark on the 27th of June 2018.

​In t​he ​news

Interna​tional and national media coverage of our research

January 2018

  • Professor Kamilla Woznica Miskowiak defended her doctoral dissertation and was awarded the doctoral degree in medical science ( on Thursday 11th of January 2018. Click here to read more.

July 2017
June 2017
  • European Psychiatric Association (EPA)

  • Watch Professor Kamilla Miskowiak giving an interview to at the EPA in 2017. 

  • Lundbeckfonden Magazine 2017

  • The Lundbeckfonden Magazine 2017 includes an interview with Dr Kamilla Miskowiak about the PRETEC-Marker studies. The magazine is available online. Click here to read the interview, "Research paves the way for novel treatment for concentration difficulties" (p. 24-27) 

lundbeckfondenmagazine2017 v1.jpg

February 2017

  • Radio interview

  • Dr Kamilla Miskowiak’s interview about electroconvulsive therapy and cognition on the national Danish radio, P1, 31st January 2017. Click here to listen to the broadcast.

November 2016
  • Lundbeckfonden Fellowship

  • Dr Kamilla Miskowiak is one of the new Lundbeckfonden Fellows 2016. The fellowship of 10 million DKK (1.34 million Euro) enables her to conduct a large neuroimaging project that aims to identify a novel brain-based biomarker model for pro-cognitive effects. A biomarker model that can help select among new candidate cognition treatments prior to large-scale clinical efficacy trials. The project may lead to a break-through in development of treatments for cognitive impairment in psychiatric disorders.

    See a 2 minute film about the project here:

​​​September 2016
  • See the latest international news about our EPO research based on a poster that was presented at the European College of Neuropsychopharmacology (ECNP) meeting in Vienna Sep 2016:

EPO boosts cognition in depressed and bipolar patients​ (Genetic Engineering & Biotechnology News)

EPO-Doping bei Depressionen​ (bild der wissenschaft)

July 2016
  • Video podcast with Dr Kamilla Miskowiak telling about EPO-associated memory improvement in mood disorders (Acta Psychiatrica Scandinavica) 

Other news

Doping hormone helps depressed remember better​ (ScienceNordic)

NeuroScene podcast interview with Dr Kamilla Miskowiak: Erythropoietin: A New Compound for Depression?
In Danish:

EPO giver depressive bedre hukommelse (
EPO ser ud til at have antidepressiv effekt​ (
Dopingmiddel kan hjælpe depressive (
EPO styrker hukommelsen hos mennesker med depression (Mental health services in the Capital Region of Denmark)
Forskning i følelser vinder frem
(Interview with Dr Kamilla Miskowiak about emotion research in the national Danish newspaper Kristeligt Dagblad)
Radio interview with Dr Kamilla Miskowiak in Danish about gender bias in science after she was given the L’Oréal For Women in Science award; fast forward to 31 minutes into the program